Ep Wealth Advisors, LLC Royalty Pharma PLC Transaction History
Ep Wealth Advisors, LLC
- $14.6 Billion
- Q2 2025
A detailed history of Ep Wealth Advisors, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Ep Wealth Advisors, LLC holds 9,314 shares of RPRX stock, worth $347,039. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,314
Previous 7,785
19.64%
Holding current value
$347,039
Previous $242,000
38.43%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
506Shares Held
309MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.74 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.36 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$858 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$815 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$671 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.3B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...